BIO-CAT-DENSA: Evaluation of Three SS-OCT and One PCI Optical Biometers in Eyes With Dense Cataract

Sponsor
OFTALVIST (Oftalmología Vistahermosa S.L) (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05239715
Collaborator
Alcon Research (Industry)
50
1
5.9
8.4

Study Details

Study Description

Brief Summary

To describe and compare the acquisition rate between different biometers in eyes with advanced cataracts

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Ocular biometry

Detailed Description

To describe and compare the acquisition rate between different biometers in eyes with advanced cataracts

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of Three SS-OCT and One PCI Optical Biometers in Eyes With Dense Cataract: Benefit of Use of the Enhance Retina Visualization Mode
Actual Study Start Date :
Jan 24, 2022
Anticipated Primary Completion Date :
Jul 24, 2022
Anticipated Study Completion Date :
Jul 24, 2022

Outcome Measures

Primary Outcome Measures

  1. To describe and compare the acquisition rate between different biometers in eyes To describe and compare the acquisition success rate between different biometers in eyes with advanced cataracts [6 months]

    Acquision succes rate is indicated by a percentage, from 0% to 100%. The biometer can obtain (success) or not (failure) the measurement. This value will be indicated for each biometer.

Secondary Outcome Measures

  1. To describe the correlation of success rate and Dysfunctional Lens Index (DLI, iTrace) [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • LOCS III cataract classification with a grade of ≥3 for nuclear, cortical or posterior subcapsular.

  • DLI index, from the ITrace device, should be ≤ 5.

Exclusion Criteria:
  • Previous continuous contact lens wear

  • Ocular trauma

  • Intraocular lens surgery

  • Poor fixation

  • Corneal disease (i.e. keratoconus)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oftalmología Vistahermosa SL Alicante Spain

Sponsors and Collaborators

  • OFTALVIST (Oftalmología Vistahermosa S.L)
  • Alcon Research

Investigators

  • Principal Investigator: Pedro Tañá, Dr., Oftalmología Vistahermosa SL

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
OFTALVIST (Oftalmología Vistahermosa S.L)
ClinicalTrials.gov Identifier:
NCT05239715
Other Study ID Numbers:
  • BIO-CAT-DENSA
First Posted:
Feb 15, 2022
Last Update Posted:
Feb 15, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by OFTALVIST (Oftalmología Vistahermosa S.L)
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 15, 2022